Business Description
EirGenix Inc
ISIN : TW0006589005
Description
EirGenix Inc is engaged in biosimilar and new drug research and development as well as biopharmaceutical contract development and manufacturing services, including cell line construction platforms, process development platforms, analytical science and protein characterisation, as well as PIC/S facilities to provide clinical trial drug production. Its services include Cell Line Development, Process Development, Analytical Science and Quality Control, cGMP manufacturing-mammalian system, cGMP manufacturing-microbial system, and Antibody Drug Conjugate.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.8 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -1.54 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 13.95 | |||||
Beneish M-Score | -1.5 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.1 | |||||
3-Year EBITDA Growth Rate | 19.4 | |||||
3-Year EPS without NRI Growth Rate | 17.8 | |||||
3-Year FCF Growth Rate | -31.3 | |||||
3-Year Book Growth Rate | 55 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.6 | |||||
9-Day RSI | 56.26 | |||||
14-Day RSI | 57.9 | |||||
6-1 Month Momentum % | -13.85 | |||||
12-1 Month Momentum % | -21.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 15.66 | |||||
Quick Ratio | 14.16 | |||||
Cash Ratio | 13.01 | |||||
Days Inventory | 355.15 | |||||
Days Sales Outstanding | 44.96 | |||||
Days Payable | 36.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.2 | |||||
Shareholder Yield % | -0.43 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.04 | |||||
Operating Margin % | -99.95 | |||||
Net Margin % | -79.5 | |||||
FCF Margin % | -122.76 | |||||
ROE % | -7.98 | |||||
ROA % | -7.25 | |||||
ROIC % | -21.61 | |||||
ROC (Joel Greenblatt) % | -20.41 | |||||
ROCE % | -7.49 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 27.53 | |||||
PB Ratio | 2.86 | |||||
Price-to-Tangible-Book | 2.86 | |||||
EV-to-EBIT | -29.18 | |||||
EV-to-EBITDA | -42.67 | |||||
EV-to-Revenue | 22.88 | |||||
EV-to-FCF | -18.27 | |||||
Price-to-Net-Current-Asset-Value | 5 | |||||
Price-to-Net-Cash | 6.29 | |||||
Earnings Yield (Greenblatt) % | -3.43 | |||||
FCF Yield % | -4.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EirGenix Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 1,026.025 | ||
EPS (TTM) (NT$) | -2.68 | ||
Beta | 0.82 | ||
Volatility % | 23.49 | ||
14-Day RSI | 57.9 | ||
14-Day ATR (NT$) | 2.737834 | ||
20-Day SMA (NT$) | 90.895 | ||
12-1 Month Momentum % | -21.5 | ||
52-Week Range (NT$) | 76.5 - 112 | ||
Shares Outstanding (Mil) | 306.11 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
EirGenix Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
EirGenix Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
EirGenix Inc Frequently Asked Questions
What is EirGenix Inc(ROCO:6589)'s stock price today?
The current price of ROCO:6589 is NT$92.70. The 52 week high of ROCO:6589 is NT$112.00 and 52 week low is NT$76.50.
When is next earnings date of EirGenix Inc(ROCO:6589)?
The next earnings date of EirGenix Inc(ROCO:6589) is .
Does EirGenix Inc(ROCO:6589) pay dividends? If so, how much?
EirGenix Inc(ROCO:6589) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |